Women hold just a small number of corporate board seats. In 2015, the 2020 Women on Boards Gender Diversity Index of Fortune 1000 companies showed that 17.9% of corporate directors were women. That number drops to 10% in biotech companies. These numbers are disproportional when you consider that women comprise about half of the total U.S. workforce, hold half of all management positions, and are responsible for almost 80% of all consumer spending.
WIB has reviewed the overwhelming evidence from various sources that state that companies with more diversity at the highest levels see a higher return on investment overall. (Catalyst report “Why Diversity Matters” )
It’s time that companies took advantage of this untapped pool of qualified board candidates. It’s time that we increased the number of women who serve on corporate boards. Women In Bio is ready to take action and make a real difference in achieving greater gender diversity on corporate boards.